Mangalam Drugs and Organics Share Price
₹105.00 -0.31 (-0.29%)
22 Jan, 2025 12:12
Start SIP in MANGALAM
Start SIPPerformance
- Low
- ₹105
- High
- ₹107
- 52 Week Low
- ₹91
- 52 Week High
- ₹145
- Open Price₹106
- Previous Close₹105
- Volume4,848
Investment Returns
- Over 1 Month -8.5%
- Over 3 Month -9.51%
- Over 6 Month -0.5%
- Over 1 Year + 3.24%
Smart Investing Starts Here Start SIP with Mangalam Drugs and Organics for Steady Growth!
Mangalam Drugs and Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 17.6
- PEG Ratio
- 0.1
- Market Cap Cr
- 166
- P/B Ratio
- 1.2
- Average True Range
- 5.42
- EPS
- 5.94
- Dividend Yield
- 0
- MACD Signal
- -1.92
- RSI
- 39.61
- MFI
- 51.49
Mangalam Drugs and Organics Financials
Mangalam Drugs and Organics Technicals
EMA & SMA
Current Price
₹105.00
-0.31
(-0.29%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹110.28
- 50 Day
- ₹112.99
- 100 Day
- ₹114.15
- 200 Day
- ₹113.29
Resistance and Support
105.83
- R3 114.86
- R2 112.02
- R1 108.67
- S1 102.48
- S2 99.64
- S3 96.29
Mangalam Drugs and Organics Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-13 | Quarterly Results | |
2024-05-21 | Audited Results | |
2024-03-15 | Others | Inter alia to consider and approve: The proposal of Scheme of Merger. |
2024-02-13 | Quarterly Results |
Mangalam Drugs and Organics F&O
About Mangalam Drugs and Organics
- NSE Symbol
- MANGALAM
- BSE Symbol
- 532637
- Chairman & Managing Director
- Mr. Govardhan Murlidhar Dhoot
- ISIN
- INE584F01014
Similar Stocks to Mangalam Drugs and Organics
Mangalam Drugs and Organics FAQs
Mangalam Drugs and Organics share price is ₹105 As on 22 January, 2025 | 11:58
The Market Cap of Mangalam Drugs and Organics is ₹166.2 Cr As on 22 January, 2025 | 11:58
The P/E ratio of Mangalam Drugs and Organics is 17.6 As on 22 January, 2025 | 11:58
The PB ratio of Mangalam Drugs and Organics is 1.2 As on 22 January, 2025 | 11:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.